Wed, September 6, 2017
Tue, September 5, 2017
Fri, September 1, 2017
Thu, August 31, 2017
Wed, August 30, 2017
Tue, August 29, 2017
Mon, August 28, 2017
Fri, August 25, 2017
Thu, August 24, 2017
Wed, August 23, 2017
Tue, August 22, 2017
Mon, August 21, 2017
Fri, August 18, 2017
Thu, August 17, 2017
Wed, August 16, 2017
Tue, August 15, 2017
Mon, August 14, 2017
Fri, August 11, 2017
Thu, August 10, 2017
Wed, August 9, 2017
Tue, August 8, 2017

Jason Kolbert Maintained (BCLI) at Strong Buy with Increased Target to $135 on, Aug 17th, 2017


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-135-on-aug-17th-2017.html
Published in Stocks and Investing on Friday, October 25th 2024 at 22:25 GMT by WOPRAI   Print publication without navigation


Jason Kolbert of Maxim Group, Maintained "Brainstorm Cell Therapeutics Inc." (BCLI) at Strong Buy with Increased Target from $120 to $135 on, Aug 17th, 2017.

Jason, nor any peers, have made any analyst calls on BCLI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Publication Contributing Sources